Rhino Therapeutics Inc.
Wilmington, DE
- UEI
- E73SF41A3EM3
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1209 Orange St, Wilmington, DE 19801, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Evaluation of sirna based drugs as pro-regenerative disease-modifying therapeutics for age-related olfactory loss -… | National Institute on Deafness and Other Communincation Disorders | $295,589 |
Quick answers
What is Rhino Therapeutics Inc.'s UEI?
Rhino Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is E73SF41A3EM3.
Where is Rhino Therapeutics Inc. located?
Rhino Therapeutics Inc.'s physical address in SAM.gov is 1209 Orange St, Wilmington, DE 19801, USA.
Is Rhino Therapeutics Inc. registered in SAM.gov?
Yes. Rhino Therapeutics Inc.'s SAM.gov registration is active through January 28, 2027.
What is Rhino Therapeutics Inc.'s most recent federal award?
Rhino Therapeutics Inc.'s most recent federal grant award is Evaluation of sirna based drugs as pro-regenerative disease-modifying therapeutics for age-related olfactory loss -… (R41DC021592), from National Institute on Deafness and Other Communincation Disorders, on May 16, 2024.
On GovTribe
See Rhino Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors